The same authors have now investigated whether C-peptide treatment improves peripheral nerve function in patients with type 1 diabetes and peripheral neuropathy. In total, 139 patients (mean age ...

A recent meta-analysis of 69 clinical trials found the risk for ischemic optic neuropathy from GLP-1 therapy is too low to be ...